AZD 8129

Drug Profile

AZD 8129

Alternative Names: AR A000002; AR A2XX; AR-A2; AZD8219

Latest Information Update: 18 Aug 2005

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator AstraZeneca
  • Class Antidepressants; Anxiolytics
  • Mechanism of Action Serotonin 1B receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Anxiety disorders; Major depressive disorder

Most Recent Events

  • 28 Jul 2005 Discontinued - Phase-II for Anxiety disorders in Sweden (unspecified route)
  • 28 Jul 2005 Discontinued - Phase-II for Depression in Sweden (unspecified route)
  • 08 Oct 2003 Phase-II clinical trials in Anxiety disorders in Sweden (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top